International Biotechnology Trust
Latest statistics and disclosures from International Biotechnology Trust's latest quarterly 13F-HR filing:
- Top 5 stock holdings are AMGN, INCY, GILD, ITCI, BMRN, and represent 30.20% of International Biotechnology Trust's stock portfolio.
- Added to shares of these 10 stocks: BMRN (+$8.4M), QURE (+$8.2M), BIIB (+$7.5M), ITCI (+$7.3M), GILD (+$6.7M), RARE (+$6.1M), AMLX, AUPH, AZN, CRSP.
- Started 9 new stock positions in CRSP, PRTA, FOLD, GMAB, AZN, Kezar Life Sciences, COGT, BPMC, VIR.
- Reduced shares in these 10 stocks: REGN (-$15M), APLS (-$12M), AMGN (-$10M), HRMY (-$8.4M), ALNY (-$7.9M), Horizon Pharma (-$6.9M), TVTX (-$6.8M), NBIX, UTHR, AKRO.
- Sold out of its positions in APLS, HCM, SAGE, TVTX, Horizon Pharma.
- International Biotechnology Trust was a net seller of stock by $-15M.
- International Biotechnology Trust has $297M in assets under management (AUM), dropping by -9.64%.
- Central Index Key (CIK): 0000942257
Tip: Access up to 7 years of quarterly data
Positions held by International Biotechnology Trust consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for International Biotechnology Trust
International Biotechnology Trust holds 65 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Amgen (AMGN) | 7.2 | $21M | -32% | 79k | 268.75 |
|
| Incyte Corporation (INCY) | 7.0 | $21M | 359k | 57.76 |
|
|
| Gilead Sciences (GILD) | 5.9 | $18M | +61% | 234k | 74.95 |
|
| Intra Cellular Therapies (ITCI) | 5.6 | $17M | +79% | 318k | 52.06 |
|
| BioMarin Pharmaceutical (BMRN) | 4.6 | $14M | +161% | 154k | 88.48 |
|
| Supernus Pharmaceuticals (SUPN) | 4.0 | $12M | -18% | 427k | 27.56 |
|
| Vera Therapeutics Cl A (VERA) | 3.5 | $10M | -22% | 758k | 13.69 |
|
| Biogen Idec (BIIB) | 3.5 | $10M | +265% | 40k | 257.06 |
|
| Harmony Biosciences Hldgs In (HRMY) | 3.5 | $10M | -44% | 315k | 32.77 |
|
| Mirati Therapeutics | 3.2 | $9.4M | -16% | 216k | 43.54 |
|
| Ultragenyx Pharmaceutical (RARE) | 3.0 | $8.9M | +212% | 250k | 35.65 |
|
| Uniqure N.v. Com Eur0.05 SHS (QURE) | 2.8 | $8.3M | +7909% | 1.2M | 6.71 |
|
| Aurinia Pharmaceuticals (AUPH) | 2.7 | $8.1M | +81% | 1.0M | 7.76 |
|
| United Therapeutics Corporation (UTHR) | 2.6 | $7.7M | -35% | 34k | 225.50 |
|
| Vertex Pharmaceuticals Incorporated (VRTX) | 2.5 | $7.3M | 21k | 347.74 |
|
|
| Regeneron Pharmaceuticals (REGN) | 2.5 | $7.3M | -67% | 8.8k | 822.69 |
|
| Illumina (ILMN) | 2.3 | $6.9M | 51k | 137.28 |
|
|
| Alnylam Pharmaceuticals (ALNY) | 2.2 | $6.5M | -54% | 37k | 177.10 |
|
| Amylyx Pharmaceuticals (AMLX) | 1.8 | $5.4M | +1080% | 295k | 18.30 |
|
| Krystal Biotech (KRYS) | 1.8 | $5.3M | 46k | 115.96 |
|
|
| Karuna Therapeutics Ord | 1.7 | $5.2M | +18% | 31k | 169.09 |
|
| Axsome Therapeutics (AXSM) | 1.4 | $4.1M | 58k | 69.83 |
|
|
| Erasca (ERAS) | 1.3 | $3.8M | +35% | 1.9M | 1.97 |
|
| ACADIA Pharmaceuticals (ACAD) | 1.3 | $3.7M | +19% | 180k | 20.81 |
|
| Revance Therapeutics | 1.1 | $3.3M | 289k | 11.46 |
|
|
| Neurocrine Biosciences (NBIX) | 1.1 | $3.2M | -58% | 29k | 112.45 |
|
| Sarepta Therapeutics (SRPT) | 1.1 | $3.2M | +42% | 27k | 121.16 |
|
| Rocket Pharmaceuticals (RCKT) | 1.1 | $3.2M | 156k | 20.47 |
|
|
| Denali Therapeutics (DNLI) | 1.1 | $3.2M | -18% | 154k | 20.60 |
|
| Astrazeneca Plc Sponsored Sponsored Adr (AZN) | 1.1 | $3.1M | NEW | 47k | 67.71 |
|
| Xenon Pharmaceuticals (XENE) | 1.1 | $3.1M | +258% | 92k | 34.12 |
|
| Crispr Therapeutics Namen Akt (CRSP) | 1.0 | $2.9M | NEW | 63k | 45.38 |
|
| Madrigal Pharmaceuticals (MDGL) | 0.9 | $2.7M | 18k | 145.87 |
|
|
| Legend Biotech Corp Sponsored Ads (LEGN) | 0.9 | $2.6M | 38k | 67.14 |
|
|
| Halozyme Therapeutics (HALO) | 0.8 | $2.4M | -34% | 62k | 38.20 |
|
| Marinus Pharmaceuticals I Com New | 0.8 | $2.3M | +222% | 290k | 8.06 |
|
| Beigene Sponsored ADR (ONC) | 0.8 | $2.3M | +45% | 13k | 179.65 |
|
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 0.7 | $2.2M | 17k | 129.37 |
|
|
| Mirum Pharmaceuticals (MIRM) | 0.7 | $2.1M | 68k | 31.54 |
|
|
| Iovance Biotherapeutics (IOVA) | 0.7 | $2.0M | +584% | 445k | 4.55 |
|
| Ionis Pharmaceuticals (IONS) | 0.7 | $1.9M | 43k | 45.33 |
|
|
| Zai Lab Adr (ZLAB) | 0.6 | $1.9M | 79k | 24.29 |
|
|
| Genmab -sp Sponsored Ads (GMAB) | 0.5 | $1.6M | NEW | 44k | 35.25 |
|
| Celldex Therapeutics Com New (CLDX) | 0.4 | $1.3M | 48k | 27.49 |
|
|
| Cogent Biosciences (COGT) | 0.4 | $1.3M | NEW | 135k | 9.73 |
|
| Dyne Therapeutics (DYN) | 0.4 | $1.2M | -54% | 138k | 8.94 |
|
| Novocure Ord Shs (NVCR) | 0.4 | $1.2M | +131% | 74k | 16.13 |
|
| Amicus Therapeutics (FOLD) | 0.4 | $1.1M | NEW | 90k | 12.14 |
|
| Cytokinetics Inc Common S Com New (CYTK) | 0.4 | $1.1M | 37k | 29.46 |
|
|
| Guardant Health (GH) | 0.4 | $1.1M | 37k | 29.62 |
|
|
| Insmed (INSM) | 0.3 | $1.0M | 40k | 25.24 |
|
|
| Blueprint Medicines (BPMC) | 0.3 | $1.0M | NEW | 20k | 50.11 |
|
| Akero Therapeutics (AKRO) | 0.3 | $935k | -76% | 19k | 50.58 |
|
| Kezar Life Sciences | 0.3 | $831k | NEW | 704k | 1.18 |
|
| Intellia Therapeutics (NTLA) | 0.3 | $758k | 24k | 31.58 |
|
|
| Prothena (PRTA) | 0.2 | $723k | NEW | 15k | 48.19 |
|
| Agios Pharmaceuticals (AGIO) | 0.2 | $594k | 24k | 24.73 |
|
|
| Beam Therapeutics (BEAM) | 0.2 | $565k | 24k | 24.03 |
|
|
| Ventyx Biosciences (VTYX) | 0.2 | $521k | 15k | 34.71 |
|
|
| Vir Biotechnology (VIR) | 0.1 | $440k | NEW | 47k | 9.36 |
|
| I-mab Sponsored Ads (IMAB) | 0.1 | $410k | 311k | 1.32 |
|
|
| Ptc Therapeutics I (PTCT) | 0.1 | $381k | 17k | 22.39 |
|
|
| Arvinas Ord (ARVN) | 0.1 | $334k | 17k | 19.62 |
|
|
| Protagonist Therapeutics (PTGX) | 0.1 | $332k | 20k | 16.68 |
|
|
| Relmada Therapeutics (RLMD) | 0.0 | $30k | 10k | 3.00 |
|
Past Filings by International Biotechnology Trust
SEC 13F filings are viewable for International Biotechnology Trust going back to 2017
- International Biotechnology Trust 2023 Q3 filed Nov. 14, 2023
- International Biotechnology Trust 2023 Q2 filed Aug. 8, 2023
- International Biotechnology Trust 2023 Q1 filed May 18, 2023
- International Biotechnology Trust 2022 Q4 filed Feb. 1, 2023
- International Biotechnology Trust 2022 Q3 filed Nov. 8, 2022
- International Biotechnology Trust 2022 Q2 filed Aug. 16, 2022
- International Biotechnology Trust 2022 Q1 filed May 20, 2022
- International Biotechnology Trust 2021 Q4 filed Feb. 15, 2022
- International Biotechnology Trust 2021 Q3 filed Nov. 12, 2021
- International Biotechnology Trust 2021 Q2 filed Aug. 11, 2021
- International Biotechnology Trust 2021 Q1 filed May 17, 2021
- International Biotechnology Trust 2020 Q4 filed Feb. 19, 2021
- International Biotechnology Trust 2020 Q3 filed Dec. 1, 2020
- International Biotechnology Trust 2020 Q2 filed July 14, 2020
- International Biotechnology Trust 2019 Q4 filed May 18, 2020
- International Biotechnology Trust 2020 Q1 filed May 18, 2020